Cell Culture Scale-Up
When culturing stem cells, "scale-up" can take on various meanings depending on your goals. Whether you want to increase the quantity or yield of your chosen cell type(s), move from traditional two-dimensional (2D) culture systems to three-dimensional (3D) platforms, or transition to large-scale clinical manufacturing, º£½ÇÆƽâ°æ Technologies can support you with tools, expertise, and guidance tailored to every aspect of scale-up.
Browse the resources below for insights on scaling up human pluripotent stem cells (hPSCs), immune cells, hematopoietic stem and progenitor cells (HSPCs), and other specialized cell types. Topics include maintaining characteristics like pluripotency and differentiation potential, meeting compliance regulations, optimizing cultures to achieve high yields, and adopting systems to mimic in vivo conditions for disease modeling, drug discovery, and therapeutic development.
On-Demand Ancillary Materials Course
In this self-paced, virtual course, you will learn how ancillary materials influence the safety, consistency, and scalability of cell and gene therapy manufacturing. Understanding these impacts is essential to successfully scaling up production while maintaining product quality and regulatory compliance.
Register Now >-
"Therapeutic T Cell Engineering" Featuring Drs. Carl June and Philipp RommelOn this episode of the Immunology Podcast, Drs. Carl June and Philipp Rommel discuss their research in lymphocyte biology, with a major translational focus on ex vivo T cell engineering for cancer and HIV cell-based therapies. -
How to Scale Up and Differentiate hPSCs in 3D Suspension CultureJoin º£½ÇÆƽâ°æ scientists Tia Sojonky and Sarah McManus to learn all about hPSC scale-up and differentiation in 3D suspension culture. This webinar provides an in-depth look at advanced techniques for scaling up and differentiating hPSCs, with some practical tips for getting started and a 15-minute Q&A session that addresses some of the most pressing questions from the field. -
“The Power of Cell Therapy†Featuring Dr. Jeffrey BluestoneOn this episode of the Immunology Podcast, Dr. Jeffrey Bluestone talks about leveraging the properties of regulatory T cells to create living cell therapies that prevent or slow autoimmune disease progression.
